Meaningful Thresholds for Change in Quantitative CT-Derived Fibrosis Extent in Idiopathic Pulmonary Fibrosis [0.03%]
特发性肺纤维化患者定量CT纤维化范围变化的有意义阈值分析
Dong Yeong Kim,Min-Ju Kim,Yu Jin Oh et al.
Dong Yeong Kim et al.
Rationale: Validated thresholds for clinically meaningful change in quantitative CT (QCT) for fibrosis extent across algorithms remain unclear in idiopathic pulmonary fibrosis (IPF). ...
Bryan S Blette,Steven M Kawut
Bryan S Blette
Implementing sleep apnea care to improve Positive Airway Pressure adherence here and across the pond [0.03%]
在河对岸实施睡眠呼吸暂停护理以改善气道正压治疗的依从性
S Amanda Sathyapala,Sairam Parthasarathy
S Amanda Sathyapala
Reply to Blette and Kawut: Surrogate Endpoints are Risky Business in Pulmonary Arterial Hypertension [0.03%]
对Blette和Kawut的回应：在肺动脉高压中，替代终点具有风险性
Shili Lin,R James White,Raymond L Benza
Shili Lin
Matthew Koslow,David Baraghoshi,Jeffrey J Swigris et al.
Matthew Koslow et al.
Methodological Considerations for Quantitative Computed Tomography-Based Prognosis in Fibrotic Interstitial Lung Disease [0.03%]
基于定量CT的纤维化间质性肺疾病的预后分析方法学考虑因素
Yanggang Hong,Zhendi Shu
Yanggang Hong
Gut microbiota associate with disease severity and survival in idiopathic pulmonary fibrosis [0.03%]
特发性肺纤维化患者肠道菌群与疾病严重程度及生存期的关系
John S Kim,Abigail Loe,Shwu-Fan Ma et al.
John S Kim et al.
Rationale: Gut microbiota modify immunity. Dysregulated immunity plays a key role in the pathogenesis of IPF. However, the role of gut microbiota in IPF pathogenesis is unknown. ...
Dupilumab in COPD: A Pooled Analysis of Emergency Department Visits, Hospital Admissions, and Systemic Corticosteroid Use [0.03%]
度普利尤单抗对慢性阻塞性肺疾病患者急诊就诊、住院和全身皮质类固醇使用情况的影响：汇总分析
Surya P Bhatt,Fernando J Martinez,Imran Satia et al.
Surya P Bhatt et al.
Rationale: In chronic obstructive pulmonary disease, exacerbations drive morbidity, healthcare resource utilization, and mortality. Hospitalization and emergency department visits reflect acute clinical instability. Syste...